Showing results (131-140 of 445) with videos related to

Sort By:
Pageof 45
Trends in Cancer|May 9, 2024
Lifileucel: the first cellular therapy approved for solid tumoursMax Julve, Mark P Lythgoe, James Larkin, et al.
Health Physics|July 17, 2026
The Effectiveness of Radiation Portal Monitors in Detecting Smuggled Rhinoceros HornsJordan A Clark, James Larkin, Craig M Marianno, et al.
Melanoma Research|December 6, 2012
Ipilimumab activity in advanced uveal melanomaMuhammad Adnan Khattak, Rosalie Fisher, Peta Hughes, et al.
Melanoma Research|September 27, 2022
Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: a multicenter case seriesJessica Louise Smith, Alexander M Menzies, Justine V Cohen, et al.
Nature Reviews. Urology|January 18, 2012
Epigenetic regulation in RCC: opportunities for therapeutic intervention?James Larkin, Xin Yi Goh, Marcus Vetter, et al.
HRB Open Research|July 1, 2020
The experience of financial burden for patients with multimorbidity: A protocol for a systematic review of qualitative researchJames Larkin, Louise Foley, Susan M Smith, et al.
Asia-Pacific Journal of Clinical Oncology|February 1, 2019
Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter studyFrancis J Ha, Lavinia Spain, Anthony Dowling, et al.
JCO Oncology Practice|May 28, 2024
Impact of Comorbidities and Drug Interactions in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Androgen Receptor Pathway InhibitorsYing Yan Zhong, Angelyn Anton, Owen Xie, et al.
Cancer Discovery|July 18, 2013
SF3B1 mutations are associated with alternative splicing in uveal melanomaSimon J Furney, Malin Pedersen, David Gentien, et al.
Frontiers in Oncology|June 2, 2015
Pazopanib-induced alopecia, an underestimated toxicity?Andrea Biondo, Helen Alexander, Komel Khabra, et al.
Pageof 45